These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11697070)

  • 1. To treat or not to treat? Managing acute symptoms in an elderly patient with Alzheimer's disease.
    Deegan R; Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2001 Oct; 39(10):12-5. PubMed ID: 11697070
    [No Abstract]   [Full Text] [Related]  

  • 2. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 3. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategies for agitation and psychosis in dementia.
    Tariot PN
    J Clin Psychiatry; 1996; 57 Suppl 14():21-9. PubMed ID: 9024333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of risperidone in Alzheimer's disease.
    Ling SM; Bonner AF; McMullen TL
    N Engl J Med; 2013 Jan; 368(2):187. PubMed ID: 23301740
    [No Abstract]   [Full Text] [Related]  

  • 6. Discontinuation of risperidone in Alzheimer's disease.
    Power GA
    N Engl J Med; 2013 Jan; 368(2):186-7. PubMed ID: 23301739
    [No Abstract]   [Full Text] [Related]  

  • 7. Discontinuation of risperidone in Alzheimer's disease.
    Gnjidic D; Hilmer SN
    N Engl J Med; 2013 Jan; 368(2):186. PubMed ID: 23301738
    [No Abstract]   [Full Text] [Related]  

  • 8. Discontinuation of risperidone in Alzheimer's disease.
    Devanand DP; Schultz SK; Sultzer DL
    N Engl J Med; 2013 Jan; 368(2):187-8. PubMed ID: 23301737
    [No Abstract]   [Full Text] [Related]  

  • 9. [Longterm treatment with Risperidone in Alzheimer's disease? No justification for more "drug deaths" in nursing homes!].
    Förstl H
    Dtsch Med Wochenschr; 2013 Jan; 138(1-2):16. PubMed ID: 23250689
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychotic symptoms, aggression and restlessness in dementia.
    Ballard C; Gray A; Ayre G
    Rev Neurol (Paris); 1999; 155 Suppl 4():S44-52. PubMed ID: 10637938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the agitation of late-life psychosis and Alzheimer's disease.
    Salzman C
    Eur Psychiatry; 2001 Jan; 16 Suppl 1():25s-28s. PubMed ID: 11520475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease.
    Creese B; Da Silva MV; Johar I; Ballard C
    Expert Rev Neurother; 2018 Jun; 18(6):461-467. PubMed ID: 29764230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients.
    Weiner MF; Tractenberg RE; Sano M; Logsdon R; Teri L; Galasko D; Gamst A; Thomas R; Thal LJ
    J Geriatr Psychiatry Neurol; 2002; 15(2):95-8. PubMed ID: 12083600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial.
    Mowla A; Pani A
    J Clin Psychopharmacol; 2010 Feb; 30(1):40-3. PubMed ID: 20075646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of aripiprazole for psychosis and agitation in dementia.
    Laks J; Miotto R; Marinho V; Engelhardt E
    Int Psychogeriatr; 2006 Jun; 18(2):335-40. PubMed ID: 16255839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zuclopenthixol acetate in a demented elderly patient with agitation.
    Myronuk L; Geizer M; Ancill RJ
    Can J Psychiatry; 1997 Apr; 42(3):325. PubMed ID: 9114954
    [No Abstract]   [Full Text] [Related]  

  • 17. Consequences of antipsychotic medications for the dementia patient.
    Devanand DP; Schultz SK
    Am J Psychiatry; 2011 Aug; 168(8):767-9. PubMed ID: 21813491
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Pipelines for Alzheimer's Disease Psychosis and Agitation.
    Oguma T; Jino K
    Chem Pharm Bull (Tokyo); 2024; 72(7):610-617. PubMed ID: 38945937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of the agitated demented elderly patient.
    Salzman C
    Hosp Community Psychiatry; 1988 Nov; 39(11):1143-4. PubMed ID: 2906318
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.
    Schneider LS; Ismail MS; Dagerman K; Davis S; Olin J; McManus D; Pfeiffer E; Ryan JM; Sultzer DL; Tariot PN
    Schizophr Bull; 2003; 29(1):57-72. PubMed ID: 12908661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.